Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
Keenan T. Hartert, Kerstin Wenzl, Jordan E. Krull, Michelle K. Manske, Vivekananda Sarangi, Yan W. Asmann, Melissa C. Larson, Matthew J. Maurer, Susan L. Slager, William R. Macon, Rebecca L. King, Andrew L. Feldman, Anita K. Gandhi, Brian K. Link, Thomas M. Habermann, Zhi‐Zhang Yang, Stephen M. Ansell, James R. Cerhan, Thomas E. Witzig, Grzegorz S. Nowakowski, Anne J. Novak
Topics & Concepts
Diffuse large B-cell lymphomaLymphomaOncologyLenalidomideMedicineInternal medicineCancer researchMultiple myelomaImmunologyBioinformaticsBiologyLymphoma Diagnosis and TreatmentViral-associated cancers and disordersPeptidase Inhibition and Analysis